Suppr超能文献

胞质谷胱甘肽转移酶介导西咪替丁亚硝胺和1-甲基-2-硝基-1-亚硝基胍脱亚硝基作用的证据。

Evidence for cytosolic glutathione transferase-mediated denitrosation of nitrosocimetidine and 1-methyl-2-nitro-1-nitrosoguanidine.

作者信息

Jensen D E, Stelman G J

机构信息

Fels Research Institute, Temple University School of Medicine, Philadelphia, PA 19140.

出版信息

Carcinogenesis. 1987 Dec;8(12):1791-800. doi: 10.1093/carcin/8.12.1791.

Abstract

Nitrosocimetidine (NC) and 1-methyl-2-nitro-1-nitrosoguanidine (MNNG) are closely related N-nitrosamidines. NC is the nitrosated derivative of cimetidine (Tagamet), an orally administered compound used extensively in the treatment of gastric ulcers. MNNG is a potent carcinogen capable of initiating tumors close to the site of administration and used experimentally to produce stomach cancer. It has become evident that the primary metabolic fate of both of these agents is denitrosation. We have discovered an activity in the cytosol fraction of hamster liver which is capable of denitrosating these nitrosamidines with an efficiency approaching 100%. The activity is heat sensitive and requires reduced glutathione as a cofactor. Inhibition of the denitrosating activity with compounds which inhibit in parallel the conjugation of glutathione with 1-chloro-2,4-dinitrobenzene (CDNB) provides evidence that the activity is glutathione transferase. One molecule of reduced glutathione is consumed in each denitrosation event. Nitrite is formed as denitrosation proceeds with a yield equivalent to 25-50% of the denitrosated product produced. Glutathione disulfide is a minor reaction product, representing 3% of the denitrosation product yield in the MNNG case and 12% in the NC case. Thus far in our survey of N-nitrosamines, N-nitrosamides and N-nitrosamidines, only the nitrosamidines appear to be vulnerable to the cytosolic denitrosating activity. In an attempt to evaluate the importance of the glutathione-dependent reaction in the intact hamster, we have depleted glutathione by pretreatment with the commonly used agents diethyl maleate (DEM) and L-buthionine-S,R-sulfoximine (L-BSO). Nitroso compound was administered i.v. and the circulating blood levels of intact and denitrosated compound 5 min after dosing quantified. NC- and MNNG-derived methylation of organ DNA was also monitored. Pretreatment had no effect on the cytosolic denitrosating or CDNB-conjugating activities. L-BSO pretreatment had no apparent effect on the denitrosative metabolism of NC or MNNG. With DEM pretreatment we obtained clear indications of a decreased rate of denitrosation and observed a 10-fold increase in MNNG-derived liver DNA methylation. The differential effects of these pretreatments are taken as an indication that DEM-sensitive processes other than those requiring glutathione dominate N-nitrosamidine denitrosation in the hamster.

摘要

亚硝基西咪替丁(NC)和1-甲基-2-硝基-1-亚硝基胍(MNNG)是密切相关的N-亚硝基脒。NC是西咪替丁(泰胃美)的亚硝化衍生物,西咪替丁是一种口服化合物,广泛用于治疗胃溃疡。MNNG是一种强效致癌物,能够在给药部位附近引发肿瘤,并在实验中用于诱发胃癌。已经很明显,这两种药物的主要代谢命运都是脱亚硝化作用。我们在仓鼠肝脏的胞质溶胶部分发现了一种活性,它能够以接近100%的效率使这些亚硝基脒脱亚硝化。该活性对热敏感,并且需要还原型谷胱甘肽作为辅助因子。用抑制谷胱甘肽与1-氯-2,4-二硝基苯(CDNB)结合的化合物来抑制脱亚硝化活性,这提供了证据表明该活性是谷胱甘肽转移酶。在每次脱亚硝化事件中消耗一分子还原型谷胱甘肽。随着脱亚硝化作用的进行会形成亚硝酸盐,其产量相当于所产生的脱亚硝化产物的25 - 50%。谷胱甘肽二硫化物是一种次要反应产物,在MNNG的情况下占脱亚硝化产物产量的3%,在NC的情况下占12%。到目前为止,在我们对N-亚硝胺、N-亚硝酰胺和N-亚硝基脒的研究中,只有亚硝基脒似乎易受胞质溶胶脱亚硝化活性的影响。为了评估谷胱甘肽依赖性反应在完整仓鼠体内的重要性,我们用常用试剂马来酸二乙酯(DEM)和L-丁硫氨酸-S,R-亚砜亚胺(L-BSO)进行预处理来耗尽谷胱甘肽。静脉注射亚硝基化合物,并对给药后5分钟时完整和脱亚硝化化合物的循环血液水平进行定量。还监测了源自NC和MNNG的器官DNA甲基化情况。预处理对胞质溶胶脱亚硝化活性或CDNB结合活性没有影响。L-BSO预处理对NC或MNNG的脱亚硝化代谢没有明显影响。用DEM预处理后,我们清楚地表明脱亚硝化速率降低,并观察到源自MNNG的肝脏DNA甲基化增加了10倍。这些预处理的不同效果表明,在仓鼠中,除了那些需要谷胱甘肽的过程外,DEM敏感的过程在N-亚硝基脒脱亚硝化中起主导作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验